Multicenter randomized trial of the prevention of gastric mucosal injury with Rabeprazol in chemotherapeutic cases of pancreatic cancer
Not Applicable
- Conditions
- Pancreatic Cancer
- Registration Number
- JPRN-UMIN000001316
- Lead Sponsor
- Faculty of Mediceine, University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients with gastric ulcer or esophagial varices 2 Lanza score, greater or equal 2 3 Direct invasion to gastric or duodenal mucosa 4 Patients who have the symptom of abdominal pain or heartburn 5 Patients who take NSAIDs or steroids 6 Patients who had taken PPI or H2RA within 14 days before start of chemothrapy 7 Patients who had liver chirrosis 8 Patients who ware given gastric resection 9 Performance status, greater or equal 3 10 Patients who had undertaken adverse event caused by PPI 11 Patients who were determined inadequate by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Modified Lanza score
- Secondary Outcome Measures
Name Time Method